Remove 2023 Remove Pharma Remove Pharmaceutical manufacturing Remove Pharmaceutical products
article thumbnail

Everything You Need to Know About Market Access in China

PM360

Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. market (source: IQVIA MIDAS, May 2023). billion people in 2023). in the top five European Union markets and 7.1%

Marketing 105
article thumbnail

Strengthening and transforming the pharmaceutical supply chain

European Pharmaceutical Review

Recent guidance published by the European Medicines Agency outlines measures that will be taken to increase preparedness for the autumn/winter 2023-2024. Recommendations were also published earlier this year for all stakeholders in the pharma supply chain. What types of medicinal products are in short supply and why?

article thumbnail

Getting ahead of regulatory changes around PFAS in pharmaceutical packaging

Clarivate

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] 5] Research is beginning to link PFAS to an increase in kidney cancer rates, reproductive challenges, and thyroid issues. [5]